Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model

Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show additional therapeutic activities on diverse inflammatory parameters. The aim of this study was to optimize a topical PGZ-loaded nanoemulsion (PGZ-NE) in order to evaluate its effectiveness for treatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinoza, Lupe Carolina, Vera-García, Rodrigo, Silva-Abreu, Marcelle, Domènech, Òscar, Badia, Josefa, Rodríguez-Lagunas, María J., Clares, Beatriz, Calpena, Ana Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150908/
https://www.ncbi.nlm.nih.gov/pubmed/32178278
http://dx.doi.org/10.3390/pharmaceutics12030255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150908/
https://www.ncbi.nlm.nih.gov/pubmed/32178278
http://dx.doi.org/10.3390/pharmaceutics12030255

Ejemplares similares